tqa3605

Small moleculeexperimental

Clinical trial activity

3 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0

Earliest trial started Dec 7, 2023 (NCT06150014)

Timeline

2020s

  1. Jan 1, 2023

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2024

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • Tree pollenImmunity, desensitized

    Tree pollen immunity, desensitized

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06990776Phase 2Jul 9, 2025Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
NCT06644417Phase 2Nov 14, 2024Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
NCT06150014Phase 1/Phase 2 (Phase 2)Dec 7, 2023Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Jiangsu Chia-tai Tianqing Pharmaceutical Co.,LtdFor profit3312023
1 organizations
Page 1 / 1